MDM2 and sarcoma: These results are in agreement with one previous report that the mdm2 gene caused resistance to doxorubicin but not to cisplatin in some sarcoma cell lines, and in these lines there was an increase in the expression of the mdr-1 gene that encodes P-gp (Cocker et al, 2001).